Latest Contracts News

Sea Forest has reported a sharp lift in SeaFeed revenue during its first full year as an ASX-listed company, but remains loss-making as it funds production and market expansion. The methane-reduction specialist ended FY26 with $27.8 million in cash and term deposits and no borrowings.

The Hydration Pharmaceuticals Company (ASX:HPC) has sharply reduced its operating losses, with Hydralyte LLC recording its first monthly EBITDA profit in August. The group remains loss-making overall, but improved margins and a lower cost base are beginning to show in the numbers.

IperionX has moved its Virginia titanium operation into 24/7 production, lifting nameplate powder capacity to about 200 tonnes a year while commissioning equipment aimed at higher-value components. The progress came alongside a US$66.8 million annual loss, US$63.5 million of operating and investing cash outflows, and continued reliance on government support, customer qualification and future capital.

Argent BioPharma has secured exclusive commercialisation rights to selected Tollovir, Tollovid and NutraVir antiviral products in a worldwide deal excluding China. The agreement adds a new commercial pillar alongside CimetrA®, but does not itself grant pharmaceutical development rights or establish clinical efficacy.

Revolver Resources has taken its Dianne Copper Mine Project from study towards construction readiness, with a larger resource, secured approvals and a forecast $125.7 million pre-tax cash flow. But the restart still depends on project-level funding before a Final Investment Decision can be made.

Structural Monitoring Systems (ASX:SMN) delivered record FY26 revenue, a sharp lift in profit and $6.0 million of free cash flow as its avionics business outpaced contract manufacturing. The balance sheet is now free of bank debt, but the next leg of the story still depends on FAA approvals and converting CVM technology into commercial revenue.

Carnarvon Energy has expanded its Bedout prospective resource inventory by 92% and secured a rig for a 2027 exploration campaign, but Dorado remains stalled before FEED and FID. The company ended FY26 with A$97.7 million in cash, no debt and a A$4.2 million after-tax loss.

Singular Health has signed a non-binding MOU to build and operate a medical imaging repository for Florida Medicaid, with approximately A$3.5 million of potential revenue subject to definitive agreements and delivery. The project could give its 3DICOM platform a state-funded infrastructure reference site, but recurring funding remains unassured.

Arena REIT delivered higher earnings, distributions and asset values in FY2026, but the failure of a major childcare tenant has forced a sharp reset in its near-term outlook. Edge Early Learning accounts for about 14% of rental income and is now in voluntary administration after missing rent.

Megaport has secured three AI infrastructure contracts worth a combined A$978.6 million, with customer prepayments covering much of the required investment. The deals push pro forma Group ARR to about A$1.1 billion and prompt upgrades to FY27 revenue and EBITDA margin guidance.

Develop Global has issued its first full-year production, operating cost and capital guidance, pairing steady Woodlawn output with the planned start of Pioneer Dome lithium sales. The growth comes with a substantial A$411 million to A$458 million investment program, while Yitirrti remains a construction story until FY28.

Perenti has secured drilling contracts across Australia, the United States and Canada expected to contribute about A$185 million in FY27 revenue, alongside an initial A$20 million underground development award in Senegal. A larger Sabodala-Massawa production phase remains conditional on Endeavour Mining issuing a notice to proceed.